The MiniMed 640G system includes the proprietary SmartGuard algorithm, which uses data from the interstitial continuous glucose sensor to stop insulin delivery if hypoglycaemia, as defined by the user ...

The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor with the MiniMed 780G system. The all-in-one sensor is said to eliminate ...

The FDA has issued an alert warning people with diabetes using a Medtronic MiniMed 630G or MiniMed 670G insulin pump of a possible cybersecurity risk, according to an agency press release. The ...

MiniMed users can call Medtronic’s 24-hour technical support team at 1-800-378-2292 if they experience any issues regarding battery life to determine whether they need a replacement pump.

GALWAY, Ireland, June 12, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following ...

The FDA approved the MiniMed 780G for users with type 1 diabetes who are at least 7 years old. Medtronic will start taking U.S. preorders for the device on May 15 and expects to start shipping ...

Medtronic plc MDT recently achieved the CE Mark for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor (CGM) that does not require any fingersticks or ...

In April, the FDA approved Medtronic's MiniMed 780G system with the Guardian 4 sensor requiring no fingersticks while in SmartGuard technology. The system is approved for users seven years old and ...

Medtronic's MiniMed 670G - the closest thing yet to an artificial pancreas - has been launched in the US. The so-called 'hybrid closed-loop' system comprises a blood glucose sensor, the MiniMed ...

References: FDA approves Medtronic MiniMed ™ 780G System – world’s first insulin pump with meal detection technology* featuring 5-minute auto corrections†§. News release. Medtronic. April ...